618 related articles for article (PubMed ID: 16080648)
41. Hereditary haemorrhagic telangiectasia--microembolization in the management of epistaxis.
Kendall BE; Joyner M; Grant H
Clin Otolaryngol Allied Sci; 1977 Aug; 2(3):249-61. PubMed ID: 589844
[No Abstract] [Full Text] [Related]
42. Natural history and control of epistaxis in a group of German patients with Rendu-Osler-Weber disease.
Folz BJ; Tennie J; Lippert BM; Werner JA
Rhinology; 2005 Mar; 43(1):40-6. PubMed ID: 15844501
[TBL] [Abstract][Full Text] [Related]
43. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
Harvey RJ; Kanagalingam J; Lund VJ
Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
[TBL] [Abstract][Full Text] [Related]
44. Hereditary hemorrhagic telangiectasis treated by the harmonic scalpel.
Ishibashi T; Takamatsu S
Head Neck; 2003 Apr; 25(4):333-6. PubMed ID: 12658738
[TBL] [Abstract][Full Text] [Related]
45. A novel treatment for patients with hereditary haemorrhagic telangiectasia.
Farnan TB; Gallagher G; Scally CM
J Laryngol Otol; 2002 Oct; 116(10):849-50. PubMed ID: 12437844
[TBL] [Abstract][Full Text] [Related]
46. A silicone nasal swab for the treatment of severe and recalcitrant epistaxis in hereditary hemorrhagic telangiectasia: an alternative to surgical nostril closure.
Bruschini L; Seccia V; Dallan I
Am J Otolaryngol; 2011; 32(4):301-3. PubMed ID: 20719406
[TBL] [Abstract][Full Text] [Related]
47. Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis.
Braak SJ; de Witt CA; Disch FJ; Overtoom TT; Westermann JJ
Rhinology; 2009 Jun; 47(2):166-71. PubMed ID: 19593974
[TBL] [Abstract][Full Text] [Related]
48. [Hereditary hemorrhagic telangiectasia].
Plauchu H; Dupuis-Girod S
Rev Prat; 2009 Sep; 59(7):899-903. PubMed ID: 19839452
[TBL] [Abstract][Full Text] [Related]
49. [Epistaxis-overview and current aspects].
Thangavelu K; Köhnlein S; Eivazi B; Gurschi M; Stuck BA; Geisthoff U
HNO; 2021 Nov; 69(11):931-942. PubMed ID: 34643746
[TBL] [Abstract][Full Text] [Related]
50. Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series.
Joshi H; Woodworth BA; Carney AS
J Laryngol Otol; 2011 Nov; 125(11):1176-80. PubMed ID: 21846415
[TBL] [Abstract][Full Text] [Related]
51. [Our experience on Rendu-Osler disease. Apropos of 19 cases].
Seidermann L; Mérol JC; Nasser T; Swierkosz F; Legros M
Rev Laryngol Otol Rhinol (Bord); 1996; 117(5):367-72. PubMed ID: 9183908
[TBL] [Abstract][Full Text] [Related]
52. [treatment of an epistaxis using a bilateral nasolabial flap in Osler-Rendu disease].
Benassayag C; Boudard P; Portmann D
Rev Laryngol Otol Rhinol (Bord); 1989; 110(3):305-7. PubMed ID: 8638056
[TBL] [Abstract][Full Text] [Related]
53. Treatment of severe epistaxis by superselective embolization: a review of 22 cases.
Ricci G; Molini E; Hamam M; Ciorba A; Altissimi G; Campanella S; Fiacca A; Pelliccioli G
Rev Laryngol Otol Rhinol (Bord); 2004; 125(4):247-51. PubMed ID: 15712697
[TBL] [Abstract][Full Text] [Related]
54. Epistaxis in hereditary haemorrhagic telangiectasia.
Haitjema T; Balder W; Disch FJ; Westermann CJ
Rhinology; 1996 Sep; 34(3):176-8. PubMed ID: 8938889
[TBL] [Abstract][Full Text] [Related]
55. Osler-Weber-Rendu syndrome.
Mani BI; Rubel AR; Chauhdary WA; Bashir A; Soe ZN; Javed N; Sharif SMA; Hla Aye MT; Chong VH
QJM; 2020 Aug; 113(8):586-587. PubMed ID: 32170936
[No Abstract] [Full Text] [Related]
56. [Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia].
Werner JA; Lippert BM; Geisthoff UW; Rudert H
Laryngorhinootologie; 1997 Aug; 76(8):495-501. PubMed ID: 9376034
[TBL] [Abstract][Full Text] [Related]
57. [Surgical treatment of the endonasal manifestations of Rendu-Osler disease].
Gignoux M; Martin H; Cajgfinger H; Gignoux B; Gadot P
J Med Lyon; 1970 Nov; 51(197):1967-8 passim. PubMed ID: 4949976
[No Abstract] [Full Text] [Related]
58. [Hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease) as an example of a rare disease relevant for oto-rhino-laryngology].
Geisthoff UW; Maune S; Schneider G
Laryngorhinootologie; 2011 Apr; 90(4):230-42; quiz 243-4. PubMed ID: 21523625
[TBL] [Abstract][Full Text] [Related]
59. Hereditary hemorrhagic telangiectasia: from epistaxis to life-threatening GI bleeding.
Ragsdale JA
Gastroenterol Nurs; 2007; 30(4):293-9; quiz 300-1. PubMed ID: 17724405
[TBL] [Abstract][Full Text] [Related]
60. Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia.
Boyer H; Fernandes P; Le C; Yueh B
Int Forum Allergy Rhinol; 2015 May; 5(5):435-40. PubMed ID: 25643928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
